Drug Shortage Report for ACCEL-CANDESARTAN
Report ID | 85706 |
Drug Identification Number | 02463784 |
Brand name | ACCEL-CANDESARTAN |
Common or Proper name | Accel Candesartan |
Company Name | ACCEL PHARMA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CANDESARTAN CILEXETIL |
Strength(s) | 32MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 tablets |
ATC code | C09CA |
ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-06-06 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-06-07 |
Company comments | Health Canada has imposed a new restriction for Candesartan finished product |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 119 LABROSSE AVE POINTE CLAIRE, QUEBEC CANADA H9R 1A3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-06-07 | English | Compare |
v4 | 2019-06-06 | French | Compare |
v3 | 2019-06-06 | English | Compare |
v2 | 2019-06-06 | French | Compare |
v1 | 2019-06-06 | English | Compare |
Showing 1 to 5 of 5